0001127602-22-014973.txt : 20220518
0001127602-22-014973.hdr.sgml : 20220518
20220518164510
ACCESSION NUMBER: 0001127602-22-014973
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220516
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keresty Georgia
CENTRAL INDEX KEY: 0001773532
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34630
FILM NUMBER: 22939761
MAIL ADDRESS:
STREET 1: C/O ASPEN TECHNOLOGY, INC.
STREET 2: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASPENTECH Corp
CENTRAL INDEX KEY: 0000929940
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
IRS NUMBER: 042739697
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-221-4302
MAIL ADDRESS:
STREET 1: 20 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ASPEN TECHNOLOGY INC /DE/
DATE OF NAME CHANGE: 19980527
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-05-16
1
0000929940
ASPENTECH Corp
AZPN
0001773532
Keresty Georgia
C/O ASPEN TECHNOLOGY, INC.
20 CROSBY DRIVE
BEDFORD
MA
01730
1
Common Stock
2022-05-16
4
D
0
3465
D
0
D
Director Stock Option (Right to Buy)
109.97
2022-05-16
4
D
0
1684
D
2029-04-16
Common Stock
1684
0
D
Director Stock Option (Right to Buy)
133.20
2022-05-16
4
D
0
1444
D
2029-09-02
Common Stock
1444
0
D
Director Stock Option (Right to Buy)
130.51
2022-05-16
4
D
0
303
D
2030-12-27
Common Stock
303
0
D
Director Stock Option (Right to Buy)
129.50
2022-05-16
4
D
0
1531
D
2031-08-31
Common Stock
1531
0
D
On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech.
At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech.
One third of the option granted at the exercise price of $109.97 will vest on the first anniversary of the grant date and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested.
Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time.
Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent.
The option granted at the exercise price of $133.20 was fully vested on the date of grant.
The option granted at the exercise price of $130.51 was fully vested on the date of grant.
The option granted at the exercise price of $129.50 was fully vested on the date of grant.
/s/ F.G. Hammond, attorney-in-fact for Ms. Keresty
2022-05-18